FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| LY-2922083, 1309435-78-6, LY-2922083 Intermediate 428-38-6, stock 989.2g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| LY-2922083, 1309435-78-6, LY-2922083 Intermediate 14282-72-5, stock 961.1g, white powder, assay by HPLC 100%, HNMR, LCMS we supply. |
| LY-2922083, 1309435-78-6, LY-2922083 Intermediate /, stock 469.5g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| LY-2922083, 1309435-78-6, LY-2922083 Intermediate 1309436-10-9, stock 507.5g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| LY-2922083, 1309435-78-6, LY-2922083 Intermediate 1292290-97-1, stock 768.8g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| LY-2922083, 1309435-78-6, LY-2922083 Intermediate 1309436-35-8, stock 768.8g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| LY-2922083, 1309435-78-6, LY-2922083 Intermediate 1309435-78-6, stock 293.3g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply. |
